Is Recombinant Human TSH a Trigger for Graves’ Orbitopathy?

Publisher： Karger

E-ISSN： 2235-0802|1|2|105-109

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.1, Iss.2, 2012-06, pp. : 105-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Graves' Orbitopathy: Imperfect Treatments for a Rare Disease

By  

European Thyroid Journal, Vol. 2, Iss. 4, 2013-11 ,pp. : 259-269

Karger

Access to resources Recommend Favorite

Guidance on That Damned Elusive Orbitopathy of Graves' Disease

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2016-03 ,pp. : 4-6

Karger

Access to resources Recommend Favorite

The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2016-03 ,pp. : 9-26

Karger

Access to resources Recommend Favorite

Recombinant Human TSH for Thyroid Remnant Ablation with 131I in Children and Adolescents with Papillary Carcinoma

By  

Hormone Research in Paediatrics, Vol. 77, Iss. 1, 2012-01 ,pp. : 59-62

Karger

Access to resources Recommend Favorite

Does Graves’ Orbitopathy Ever Disappear? Answers to an Old Question

By  

European Thyroid Journal, Vol. 6, Iss. 5, 2017-06 ,pp. : 263-270

Karger

Access to resources Recommend Favorite